832 related articles for article (PubMed ID: 26662960)
1. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma.
Jung J; Park SY; Park SJ; Park J
Tumour Biol; 2016 Jun; 37(6):7149-54. PubMed ID: 26662960
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
[TBL] [Abstract][Full Text] [Related]
3. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer.
Xie X; Luo KJ; Hu Y; Wang JY; Chen J
Dis Esophagus; 2016 Jan; 29(1):79-85. PubMed ID: 25410116
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
6. Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma.
Feng JF; Huang Y; Chen QX
World J Surg Oncol; 2014 Mar; 12():58. PubMed ID: 24641770
[TBL] [Abstract][Full Text] [Related]
7. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
Fu X; Li T; Dai Y; Li J
BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of preoperative inflammatory response biomarkers in patients undergoing curative thoracoscopic esophagectomy for esophageal squamous cell carcinoma.
Hirahara N; Matsubara T; Kawahara D; Nakada S; Ishibashi S; Tajima Y
Eur J Surg Oncol; 2017 Feb; 43(2):493-501. PubMed ID: 28034501
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma.
Zhang Y; Jiang C; Li J; Sun J; Qu X
Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119
[TBL] [Abstract][Full Text] [Related]
10. Preoperative NLR and PLR in the middle or lower ESCC patients with radical operation.
He YF; Luo HQ; Wang W; Chen J; Yao YW; Yan Y; Wu SS; Hu XX; Ke LH; Niu JY; Li HM; Ji CS; Hu B
Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26947428
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis.
Yodying H; Matsuda A; Miyashita M; Matsumoto S; Sakurazawa N; Yamada M; Uchida E
Ann Surg Oncol; 2016 Feb; 23(2):646-54. PubMed ID: 26416715
[TBL] [Abstract][Full Text] [Related]
12. Preoperative neutrophil-to-lymphocyte ratio is an independent prognostic marker in patients with laryngeal squamous cell carcinoma.
Tu XP; Qiu QH; Chen LS; Luo XN; Lu ZM; Zhang SY; Chen SH
BMC Cancer; 2015 Oct; 15():743. PubMed ID: 26482899
[TBL] [Abstract][Full Text] [Related]
13. The Preoperative Neutrophil-To-Lymphocyte Ratio Is a Novel Immune Parameter for the Prognosis of Esophageal Basaloid Squamous Cell Carcinoma.
Xiao Q; Zhang B; Deng X; Wu J; Wang H; Wang Y; Wang W
PLoS One; 2016; 11(12):e0168299. PubMed ID: 27959959
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy.
Hirahara N; Matsubara T; Mizota Y; Ishibashi S; Tajima Y
BMC Surg; 2016 Sep; 16(1):66. PubMed ID: 27650456
[TBL] [Abstract][Full Text] [Related]
15. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer.
Sharaiha RZ; Halazun KJ; Mirza F; Port JL; Lee PC; Neugut AI; Altorki NK; Abrams JA
Ann Surg Oncol; 2011 Nov; 18(12):3362-9. PubMed ID: 21547702
[TBL] [Abstract][Full Text] [Related]
16. [Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after radical resection of esophageal squamous cell carcinoma].
Chen H; He J
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):294-7. PubMed ID: 24989917
[TBL] [Abstract][Full Text] [Related]
17. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
Ji WH; Jiang YH; Ji YL; Li B; Mao WM
Dis Esophagus; 2016 Jul; 29(5):403-11. PubMed ID: 25625421
[TBL] [Abstract][Full Text] [Related]
18. The pre-treatment neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and red cell distribution width predict prognosis in patients with laryngeal carcinoma.
Kara M; Uysal S; Altinişik U; Cevizci S; Güçlü O; Dereköy FS
Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):535-542. PubMed ID: 27520567
[TBL] [Abstract][Full Text] [Related]
19. Preoperative neutrophil-to-lymphocyte ratio is a more valuable prognostic factor than platelet-to-lymphocyte ratio for nonmetastatic rectal cancer.
Li H; Song J; Cao M; Wang G; Li L; Zhang B; Li Y; Xu W; Zheng J
Int Immunopharmacol; 2016 Nov; 40():327-331. PubMed ID: 27664571
[TBL] [Abstract][Full Text] [Related]
20. Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer.
Hirahara N; Matsubara T; Hayashi H; Takai K; Fujii Y; Tajima Y
Eur J Surg Oncol; 2015 Oct; 41(10):1308-15. PubMed ID: 26235238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]